KR20030086849A - A composition for whitening containing crown daisy extract - Google Patents
A composition for whitening containing crown daisy extract Download PDFInfo
- Publication number
- KR20030086849A KR20030086849A KR1020020025045A KR20020025045A KR20030086849A KR 20030086849 A KR20030086849 A KR 20030086849A KR 1020020025045 A KR1020020025045 A KR 1020020025045A KR 20020025045 A KR20020025045 A KR 20020025045A KR 20030086849 A KR20030086849 A KR 20030086849A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- mugwort
- melanin
- whitening
- weight
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 68
- 230000002087 whitening effect Effects 0.000 title claims abstract description 37
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 244000067456 Chrysanthemum coronarium Species 0.000 title abstract description 7
- 235000007871 Chrysanthemum coronarium Nutrition 0.000 title abstract description 6
- 239000000469 ethanolic extract Substances 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000004480 active ingredient Substances 0.000 claims abstract description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 62
- 240000006891 Artemisia vulgaris Species 0.000 claims description 49
- 238000000034 method Methods 0.000 claims description 6
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 claims description 5
- 229940119569 wormwood extract Drugs 0.000 claims description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 20
- 102000003425 Tyrosinase Human genes 0.000 abstract description 17
- 108060008724 Tyrosinase Proteins 0.000 abstract description 17
- 238000003860 storage Methods 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 17
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 13
- 235000003097 Artemisia absinthium Nutrition 0.000 description 13
- 240000001851 Artemisia dracunculus Species 0.000 description 13
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 13
- 239000001138 artemisia absinthium Substances 0.000 description 13
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 13
- 230000005764 inhibitory process Effects 0.000 description 12
- 230000002401 inhibitory effect Effects 0.000 description 10
- 230000008099 melanin synthesis Effects 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 210000002752 melanocyte Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 208000001382 Experimental Melanoma Diseases 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000035755 proliferation Effects 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000004663 cell proliferation Effects 0.000 description 5
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 4
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- -1 2-thiophenyl Chemical group 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000021164 cell adhesion Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000005445 natural material Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical class C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QRTADFOPPOKFDH-UHFFFAOYSA-N 20,21-dihydroxyhenicosanoic acid Chemical class OCC(O)CCCCCCCCCCCCCCCCCCC(O)=O QRTADFOPPOKFDH-UHFFFAOYSA-N 0.000 description 1
- KRZBCHWVBQOTNZ-PSEXTPKNSA-N 3,5-di-O-caffeoyl quinic acid Chemical compound O([C@@H]1C[C@](O)(C[C@H]([C@@H]1O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 KRZBCHWVBQOTNZ-PSEXTPKNSA-N 0.000 description 1
- DNZQDZDGNZZGCU-UHFFFAOYSA-N 3,5-dicaffeoy-4-succinylquinic acid Natural products OC(=O)CCC(=O)OC1C(OC(=O)C=CC=2C=C(O)C(O)=CC=2)CC(O)(C(O)=O)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 DNZQDZDGNZZGCU-UHFFFAOYSA-N 0.000 description 1
- MVCIFQBXXSMTQD-UHFFFAOYSA-N 3,5-dicaffeoylquinic acid Natural products Cc1ccc(C=CC(=O)OC2CC(O)(CC(OC(=O)C=Cc3ccc(O)c(O)c3)C2O)C(=O)O)cc1C MVCIFQBXXSMTQD-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 101710083587 Antifungal protein Proteins 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 241000723353 Chrysanthemum Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002214 flavonoid derivatives Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000015134 garland chrysanthemum Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 쑥갓 추출물을 함유하는 미백조성물에 관한 것으로, 좀더 상세하게는 천연 미백소재인 쑥갓의 냉동건조 분말, 열수 추출물 또는 에탄올 추출물을 함유하는 미백조성물에 관한 것이다.The present invention relates to a whitening composition containing mugwort extract, and more particularly to a whitening composition containing a freeze-dried powder, hot water extract or ethanol extract of mugwort, which is a natural whitening material.
쑥갓(Chrysanthemum coronariumL.)은 원산지인 유럽으로부터 동아시아에 전파되어 채소로 이용된 것으로 현재 채소로 이용되고 있는 지역은 인도, 동남아시아전역, 중국, 한국, 일본 등으로서, 쑥갓은 단백질 2%, 탄수화물 2~3%, 지방 0.3%, 섬유 0.9%, 회분 1.5%를 함유하고 있다.Wormwood chrysanthemum ( Chrysanthemum coronarium L.) spread from East of origin to East Asia and used as vegetables. Regions currently used as vegetables are India, Southeast Asia, China, Korea, Japan, etc. ˜3%, fat 0.3%, fiber 0.9%, ash 1.5%.
쑥갓의 비타민 함량은 쑥갓 100g에 대해서 비타민 A 6,000 I.U., 비타민 B1 100r, 비타민 B2 60r, 비타민 C 60mg 으로서 매우 많은 편이고, 홍당무 등에 다량 함유되어 있는 카로틴(carotene) 및 미네랄로서 칼슘을 함유하고 있는 것도 특징이라 할 수 있으며, 필수 아미노산인 라이신(lysine)을 다량으로 함유하고 있다.The content of vitamins in mugwort is 6,000 IU, vitamin B1 100r, vitamin B2 60r, and vitamin C 60mg per 100g of mugwort, and it also contains calcium as carotene and mineral which are contained in blush, etc. It can be said that it contains a large amount of lysine (lysine), an essential amino acid.
인체의 피부색은 햇빛을 받으면 검게 변하게 되는데, 이러한 원인은 검은 색소의 일종인 멜라닌(melanin)이 인체에 형성되기 때문으로, 멜라닌은 동물, 식물 및 미생물에 널리 존재하는 페놀류(phenols)의 고분자 물질로서 검은 색소와 단백질로 이루어져 있다.The skin color of the human body turns black when it is exposed to sunlight. This is because melanin (melanin), a kind of black pigment, is formed in the human body. It consists of black pigment and protein.
멜라닌은 멜라닌 형성세포 내의 타이로신(tyrosine)을 기질로 하여 타이로시나제(tyrosinase)가 작용하여 도파퀴논(dopaquinone)이 생성되고 이 도파퀴논이 산화반응 및 효소반응을 거쳐 합성된다.Melanin is tyrosine in melanocytes (tyrosine) as a substrate to act as a tyrosinase (tyrosinase) to produce a dopaquinone (dopaquinone) is synthesized through the oxidation and enzyme reaction.
따라서, 인체 피부에 멜라닌의 합성을 억제하기 위해서는 타이로시나제의 활성을 억제시키거나, 멜라닌 생성과정 중의 일부반응을 억제하는 효과가 있는 물질이 필요한데, 타이로시나제 저해제(tyrosinase inhibitor)로 아스코빈산(ascorbic acid), 코티코스테로이드(corticosteroids), 레티노이드(retinoids) 아제락산 (azelaic acid), 하이드로퀴논(hydroquinone), 하이드록시아니솔(hydroxyanisole), 코지산(kojic acid), 아부틴(arbutin) 등이 있으나, 이러한 화학합성 물질은 안전성, 안정성 및 장기보관시 변색, 변취 등과 같은 문제점이 있었다.Therefore, in order to inhibit the synthesis of melanin in the human skin, a substance having an effect of inhibiting the activity of tyrosinase or inhibiting some reactions during the production of melanin is required. As a tyrosinase inhibitor, Ascorbic acid, corticosteroids, retinoids, azelaic acid, hydroquinone, hydroxyanisole, kojic acid, arbutin, etc. However, these chemical synthetic materials have problems such as safety, stability and discoloration and deodorization during long-term storage.
상기와 같은 문제점을 극복하기 위하여 천연물질인 식물의 추출물을 미백성분으로 활용하기 위한 연구가 지속적으로 이루어져 왔는데, 이와 관련한 공지기술로는 상백피의 성분을 이용한 미백화장료(한국공개특허 제92-2109호, 일본공개특허 소화 제 55-44375호, 일본공개특허 소화 제64-26507호, 일본공개특허 소화 제64-83009호, 일본공개특허 평성 제1-256587호), 감초의 성분을 이용한 미백화장료(한국공개특허 제92-2109호, 일본공개특허 소화 제60-214721호, 일본공개특허 소화 제63-23809호, 일본공개특허 평성 제1-149706호) 등이 개시되어 있다.In order to overcome the above problems, research has been continuously conducted to utilize the extracts of plants, which are natural substances, as a whitening ingredient. As a well-known technique, the whitening cosmetics using the ingredients of baekbaekpi (Korean Patent Publication No. 92-2109) , Japanese Patent Application No. 55-44375, Japanese Patent Application No. 64-26507, Japanese Patent Application No. 64-83009, Japanese Patent Application Publication No. 1-256587), Whitening cosmetics using ingredients of licorice ( Korean Patent Application Publication No. 92-2109, Japanese Patent Application Publication No. 60-214721, Japanese Patent Application Publication No. 63-23809, Japanese Patent Application Publication No. Hei 1-49706), and the like.
또한, 작약의 성분을 이용한 미백화장료(일본공개특허 소화 제61-246109호), 계피의 성분을 이용한 미백화장료(일본공개특허 소화 제63-30403호), 치자열매 추출물을 이용한 미백조성물(한국공개특허 제2002-4896호), 유근피 추출물을 함유하는 항노화 화장품 조성 (한국공개특허 제2002-4896호), 천련자 추출물을 함유하는 미백용 조성물(한국공개특허 제2001-93861호), 파고지 추출물을 함유하는 미백용 조성물(한국공개특허 제2001-93859호) 및 오수유 추출물을 함유하는 미백용 조성물(한국공개특허 제2001-93860호) 등이 개시되어 있다.Also, whitening cosmetics using ingredients of peony (Japanese Patent Laid-Open No. 61-246109), whitening cosmetics using ingredients of cinnamon (Japanese Laid-Open Patent No. 63-30403), and whitening compositions using gardenia berry extract (Korean publication) Patent No. 2002-4896), anti-aging cosmetic composition containing the extract of Yu-geun-pi (Korea Patent Publication No. 2002-4896), whitening composition containing Cheonnyeonja extract (Korean Patent No. 2001-93861), pagoji extract A whitening composition (Korean Patent Publication No. 2001-93859) and a whitening composition (Korean Patent Publication No. 2001-93860) containing a sewage extract are disclosed.
상기와 같은 다수의 식물추출물이 타이로시나제에 작용하여 멜라닌의 합성을 억제한다는 사실이 밝혀졌으나, 이와 같은 천연성분도 강한 저해활성을 유지하면서 안전성, 안정성 및 변색 가능성 등의 문제를 완전히 해결하기에는 미흡한 실정이다.It has been found that many of the above plant extracts act on tyrosinase to inhibit melanin synthesis, but such natural ingredients are insufficient to completely solve problems such as safety, stability, and discoloration potential while maintaining strong inhibitory activity. It is true.
이에 본 발명자들은 상기와 같은 문제점을 해결하기 위한 연구를 수행하여 천연소재인 쑥갓추출물을 이용하여 안정성을 유지하면서 멜라닌세포의 증식억제 및 멜라닌의 생성에 관여하는 타이로시나제의 활성을 억제하여 멜라닌의 생성량을 감소시킬 수 있는 미백조성물을 제조할 수 있음을 알아내고 본 발명을 완성하였다.Therefore, the present inventors conducted a study to solve the above problems by maintaining the stability using the wormwood extract, a natural material while inhibiting the activity of tyrosinase involved in the inhibition of melanocyte proliferation and the production of melanin to melanin The present invention was completed by finding out that a whitening composition capable of reducing the amount of produced was prepared.
따라서, 본 발명의 목적은 쑥갓추출물을 유효성분으로 함유하는 새로운 미백조성물을 제공함에 있다.Accordingly, it is an object of the present invention to provide a new whitening composition containing the mugwort extract as an active ingredient.
도 1 은 본 발명에 의한 쑥갓추출물의 멜라닌세포 증식억제 효과,1 is a melanocyte proliferation inhibitory effect of mugwort extract according to the present invention,
도 2 는 본 발명에 의한 쑥갓추출물의 도파 옥시다제 활성 억제효과,2 is an effect of inhibiting the dopa oxidase activity of mugwort extract according to the present invention,
도 3 은 본 발명에 의한 쑥갓추출물의 멜라닌생성 억제효과,3 is a melanin production inhibitory effect of mugwort extract according to the present invention,
도 4 는 본 발명에 의한 쑥갓 에탄올추출물 1000㎍/㎖ 처리 3일 후 B16 멜라노마 세포의 형태를 나타낸 것이다.Figure 4 shows the morphology of B16 melanoma cells three days after treatment with 1000 ㎍ / ㎖ ethanol extract according to the present invention.
쑥갓(crown daisy)의 전초에는 항산화 효과를 나타내는 플라보노이드(flavonoid) 계열의 유도체 성분이 많이 발견되고 있는데, 그 성분들로는 카페인산(caffeic acid), 클로로지닌산(chlorogenic acid), 3,5-디카페오일퀴닌산(3,5-dicaffeoylquinic acid), 4-썩니닐-3,5-디카페오닐퀴닌산(4-succinyl-3,5-dicaffeoylquinic acid), 에모딘(emodin), 티오펜(N-이소부틸-6(2-티오페닐)-2,4-헥사디엔아미드-1,8-디하이드록시앤쓰로퀴논(thiophene(N-isobutyl-6-(2-thiophenyl)-2,4-hexadienamide-1,8-dihydroxyanthroquinone), 쿼세틴(quercetin) 및 그 글리코사이드 유도체(glycoside derivatives), 루틴(rutin) 및 이소쿼세틴(isoquercetin) 등이 알려져 있다.In the outposts of wormwood (crown daisy), many flavonoid derivatives have antioxidant properties, including caffeic acid, chlorogenic acid, and 3,5-dicafee. Oilquinic acid (3,5-dicaffeoylquinic acid), 4-reninyl-3,5-dicafeonylquinic acid (4-succinyl-3,5-dicaffeoylquinic acid), emodin, thiophene (N- Isobutyl-6 (2-thiophenyl) -2,4-hexadieneamide-1,8-dihydroxyandthroquinone (thiophene (N-isobutyl-6- (2-thiophenyl) -2,4-hexadienamide- 1,8-dihydroxyanthroquinone, quercetin and its glycoside derivatives, rutin and isoquercetin are known.
쑥갓에 함유되어 있는 비타민 C, 카로티노이드(carotinoid) 및 그 외 풍부한 항산화 성분들은 심장혈관계 질병을 예방하고, 크리산코린(chrysancorin)은 항균 작용이 있는 것으로 보고되고 있다(Takenaka M. et al., M. Stability andbioavailability of antioxidants in garland (Chrysanthemum coronarium L.)Biosci Biotechnol Biochem. 2000 Dec;64(12):2689-91 ; Gins V.K. et al., Oxyanthraquinones and flavonoids from garland chrysanthenumPrikl Biokhim Mikrobiol. 2000 May-Jun;36(3):344-53 ; Wang H. et al., Purification of chrysancorin, a novel antifungal protein with mitogenic activity from garland chrysanthemum seedsBiol Chem. 2001 Jun;382(6):947-51).Vitamin C, carotinoids and other rich antioxidants in wormwood are known to prevent cardiovascular diseases, and chrysancorin has been reported to have antimicrobial activity (Takenaka M. et al., M Stability and bioavailability of antioxidants in garland (Chrysanthemum coronarium L.) Biosci Biotechnol Biochem . 2000 Dec; 64 (12): 2689-91; Gins VK et al., Oxyanthraquinones and flavonoids from garland chrysanthenum Prikl Biokhim Mikrobiol . 2000 May-Jun; 36 (3): 344-53; Wang H. et al., Purification of chrysancorin, a novel antifungal protein with mitogenic activity from garland chrysanthemum seeds Biol Chem . 2001 Jun; 382 (6): 947-51).
본 발명에 의한 미백조성물에는 쑥갓의 동결건조 추출물, 쑥갓의 열수 추출물 및 쑥갓의 에탄올 추출물로 구성된 군에서 선택된 1종 또는 2종 이상의 쑥갓추출물이 사용된다.In the whitening composition according to the present invention, one or two or more wormwood extracts selected from the group consisting of lyophilized extract of mugwort, hot water extract of mugwort, and ethanol extract of mugwort are used.
본 발명에 사용되는 쑥갓의 동결건조 추출물(crude extracts)은 믹서 또는 균질기(homogenizer)에 넣어 잘게 간 쑥갓을 냉동고(deep freezer)에서 오버나잇(overnight)시킨 후 냉동건조기(freeze dryer)로 2-3일 동안 완전히 건조시켜 제조한다.The freeze-dried extracts of mugwort used in the present invention are added to a mixer or homogenizer, and then overnight in a deep freezer. Prepare by drying completely for 3 days.
본 발명에 사용되는 쑥갓의 열수추출물(water soluble extracts)은 완전히 건조된 쑥갓에 증류수를 첨가하고 열수중탕으로 4-6시간 추출하여 여과한 추출물을 냉동고에서 오버나잇시킨 후, 냉동건조기에서 2-3일 동안 건조시켜 제조한다.The water soluble extracts of mugwort used in the present invention are added to distilled water to completely dried mugwort and extracted with hot water bath for 4-6 hours, after the filtered extract is overnight in a freezer, 2-3 in a freeze dryer. Prepared by drying for days.
또한, 본 발명에 사용되는 쑥갓의 에탄올 추출물(ethanol soluble extracts)은 완전히 건조된 쑥갓에 에탄올을 첨가하고 45-55℃에서 4-6시간 추출하여 여과한 추출물을 냉동고에서 오버나잇시킨 후 냉동건조기에서 2-3일 동안 완전히 건조시켜 제조한다.In addition, ethanol soluble extracts of wormwood used in the present invention (ethanol soluble extracts) is added to the ethanol to completely dried mugwort and extracted for 4-6 hours at 45-55 ℃ over night the filtered extract in the freezer and then in a freeze dryer Prepare by drying completely for 2-3 days.
본 발명에서는 세포증식 실험, 타이로시나제 활성실험, 멜라닌양 측정실험 등을 통해 상기에서 제조한 쑥갓추출물이 멜라닌세포에 미치는 영향을 검증하였는데, 본 발명에 사용된 쑥갓추출물이 멜라닌세포의 증식을 억제하고, 멜라닌의 생성에 관여하는 티로시나제의 활성을 억제시킬 뿐만 아니라 멜라닌양을 감소시킴을 관찰함으로써 미백효과가 있음을 확인할 수 있었다.In the present invention, the effects of the above-mentioned mugwort extracts on melanocytes were verified through cell proliferation experiments, tyrosinase activity experiments, melanin amount measurement experiments, and the mugwort extracts used in the present invention were used for the proliferation of melanocytes. By inhibiting and inhibiting the activity of tyrosinase involved in the production of melanin as well as reducing the amount of melanin, it was confirmed that there is a whitening effect.
본 발명에 의한 미백조성물은 상기의 쑥갓추출물을 0.01-10 중량%, 바람직하게는 0.01-5 중량% 함유하는데, 쑥갓추출물을 0.01 중량% 이하를 함유하면 미백효과가 없고, 10 중량% 이상을 함유하면 안전성 또는 제형상의 조제에 문제가 생길 수 있기 때문이다.The whitening composition according to the present invention contains 0.01-10% by weight, preferably 0.01-5% by weight of the mugwort extract, but if it contains 0.01% by weight or less of mugwort extract, it does not have a whitening effect and contains 10% by weight or more. This is because there may be a problem in the safety or formulation formulation.
본 발명에 의한 미백조성물은 화장용 크림, 화장수, 화장용 유액, 미용수 등과 같은 화장료나 액상 및 고상의 비누 또는 시럽제, 연고, 크림제제, 전제, 틴크제, 엑기스제, 한방제제, 침제, 전제 등과 같은 내복 또는 외용의 제제로 조제될 수 있는데, 미백효과를 증진시키기 위하여 피부흡수 촉진물질을 함유할 수 있다.The whitening composition according to the present invention may be used in cosmetics such as cosmetic creams, lotions, cosmetic emulsions, beauty waters, liquid or solid soaps or syrups, ointments, creams, premises, tinctures, extracts, herbal preparations, acupuncture agents, premises It may be formulated as an oral or external preparation, and may contain a skin absorption promoting substance to enhance the whitening effect.
이하 본 발명을 실시예 및 시험예를 통하여 보다 상세히 설명한다. 그러나 본 발명의 기술적 범위가 이들 실시예 및 시험예에 국한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples and Test Examples. However, the technical scope of the present invention is not limited to these examples and test examples.
<실시예 1> (쑥갓 동결건조 추출물의 제조)<Example 1> (Preparation of mugwort lyophilized extract)
물에 씻어 깨끗하게 준비된 쑥갓 1kg을 균질기에 넣어 고르게 균질화한 후, -70℃의 냉동고에서 하룻밤 동안 오버나잇시킨 다음 감압하에서 -50℃ 조건의 냉동건조기에서 3일 동안 완전히 건조시켜 쑥갓 동결건조 추출물 18.923g을 제조하였다.1kg of wormwood freshly prepared by washing in water was homogenized evenly in a homogenizer, and then overnight overnight in a -70 ° C freezer, and then completely dried in a freeze dryer at -50 ° C under reduced pressure for 1 day 23g freeze-dried extract Was prepared.
<실시예 2> (쑥갓 열수추출물의 제조)<Example 2> (Preparation of mugwort hot water extract)
실시예 1에서 제조한 완전히 건조된 쑥갓 동결건조 추출물 5g에 100ml의 증류수를 첨가하고 80℃에서 열수중탕으로 5시간 동안 추출하였다.100 ml of distilled water was added to 5 g of the dried dried mugwort lyophilized extract prepared in Example 1, and extracted with hot water bath at 80 ° C. for 5 hours.
상기에서 얻은 추출물을 화트만(Whatman) No.2 여과지로 여과한 추출물을 -70℃의 냉동고에서 하룻밤 동안 오버나잇시킨 다음, 감압하에서 -50℃ 조건의 냉동건조기에서 3일 동안 완전히 건조시켜 쑥갓 열수추출물 44.75mg(8.951g/쑥갓1kg)을 제조하였다.The extract obtained above was filtered through Whatman No. 2 filter paper overnight at -70 ° C freezer, and then completely dried in a freeze dryer at -50 ° C under reduced pressure for 3 days. 44.75 mg (8.951 g / wormwood 1 kg) extract was prepared.
<실시예 3> (쑥갓 에탄올 추출물의 제조)<Example 3> (Preparation of mugwort ethanol extract)
실시예 1에서 제조한 완전히 건조된 쑥갓 동결건조 추출물 5g에 100ml의 70% 에탄올을 첨가하고 50℃에서 5시간 동안 추출하였다.100 g of 70% ethanol was added to 5 g of the fully dried mugwort lyophilized extract prepared in Example 1, and extracted at 50 ° C. for 5 hours.
상기에서 얻은 추출물을 광목으로 여과한 추출물을 -70℃의 냉동고에서 하룻밤 동안 오버나잇시킨 다음, 감압하에서 -50℃ 조건의 냉동건조기에서 3일 동안 완전히 건조시켜 쑥갓 에탄올 추출물 10.78mg (2.157g/쑥갓1kg)을 제조하였다.The extract obtained by filtering the extract obtained above with a tree was overnight overnight in a -70 ° C freezer, and then completely dried in a freeze dryer at -50 ° C under reduced pressure for 3 days, and 10.78mg of ethanol extract (2.157g / wormwood) 1 kg) was prepared.
<실시예 4> (쑥갓추출물을 함유하는 영양화장수의 제조)Example 4 (Preparation of Nutrients Containing Mugwort Extract)
실시예 2에서 제조한 쑥갓 열수추출물 5 중량부, 밀납 5 중량부, 폴리솔베이트 60 1 중량부, 솔비탄세스퀴올레이드 0.5 중량부, 유동파라핀 3 중량부, 스쿠알란 3 중량부, 카프릭트리글리세라이드 3 중량부, 글리세린 2.5 중량부, 부틸렌글리콜 2.5 중량부, 프로필렌글리콜 2.5 중량부, 카르복시비닐폴리머 0.1 중량부, 트리에탄올 아민 0.1 중량부와 적량의 방부제, 색소, 향료 및 정제수를 이용하여 통상의 방법으로 영양화장수를 제조하였다.5 parts by weight of mugwort hot water extract prepared in Example 2, 5 parts by weight of beeswax, 1 part by weight of polysorbate 60, 0.5 parts by weight of sorbitassesquiolade, 3 parts by weight of liquid paraffin, 3 parts by weight of squalane, capric triglyceride 3 parts by weight, glycerin 2.5 parts by weight, butylene glycol 2.5 parts by weight, propylene glycol 2.5 parts by weight, 0.1 parts by weight of carboxyvinyl polymer, 0.1 parts by weight of triethanol amine and a suitable amount of preservatives, pigments, flavors and purified water The nutritional cosmetics were prepared.
<실시예 5> (쑥갓추출물을 함유하는 크림의 제조)Example 5 Preparation of Cream Containing Mugwort Extract
실시예 3에서 제조한 쑥갓 에탄올추출물 10중량부, 스테아릴 알콜 8 중량부, 스테아린산 2 중량부, 스테아린산 콜레스테롤 2 중량부, 스쿠알란 4 중량부, 2-옥틸도데실알콜 6 중량부, 폴리옥시에틸렌알콜 에스테르 3중량부, 글리세릴 모노스테아린산 에스텔 2 중량부, 프로필렌글리콜 5 중량부 및 정제수를 이용하여 통상의 방법으로 크림을 제조하였다.10 parts by weight of wormwood ethanol extract prepared in Example 3, 8 parts by weight of stearyl alcohol, 2 parts by weight of stearic acid, 2 parts by weight of stearic acid cholesterol, 4 parts by weight of squalane, 6 parts by weight of 2-octyldodecyl alcohol, polyoxyethylene alcohol Cream was prepared by the conventional method using 3 weight part of esters, 2 weight part of glyceryl monostearic acid esters, 5 weight part of propylene glycol, and purified water.
<시험예 1> (B16 멜라노마 세포배양)<Test Example 1> (B16 melanoma cell culture)
본 발명에 의한 미백조성물에 사용된 쑥갓 추출물의 세포증식, 타이로시나제 활성 및 멜라닌양 측정에 이용되는 B16 멜라노마 세포(B16 melanoma cell)를 RPMI1640 기본배지에 10% 소태아혈청(fetal bovine serum), 1% 페니실닌-스트렙토마이신(penicillin-streptomycin)을 첨가한 배지로 37℃, 5% CO2의 조건에서 배양하였는데, 배양중의 배지는 3일에 한번씩 갈아주었다.B16 melanoma cells used for cell proliferation, tyrosinase activity, and melanin levels of wormwood extracts used in the whitening composition according to the present invention, 10% fetal bovine serum (fetal bovine serum) in RPMI1640 basic medium 1% penicillin-streptomycin was added to the culture medium at 37 ° C. and 5% CO 2. The culture medium was changed every three days.
<시험예 2> (세포증식 억제효과 측정)Test Example 2 (Measurement of Cell Proliferation Inhibition Effect)
본 발명에 의한 미백조성물에 사용된 쑥갓추출물의 멜라닌 세포증식 억제효과를 알아보기 위하여 실시예 1 내지 실시예 3에서 제조한 쑥갓 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE)을 처리한 B16 멜라노마 세포의 증식율을 측정한 결과를 표 1 및 도 1에 나타내었다.Mugwort freeze-dried extract (CE), mugwort hot water extract (WE) and mugwort hot water extract (WE) prepared in Examples 1 to 3 in order to determine the melanin cell growth inhibition effect of mugwort extract used in the whitening composition according to the present invention The results of measuring the proliferation rate of B16 melanoma cells treated with EE) are shown in Table 1 and FIG. 1.
세포증식율은 다음과 같은 방법으로 측정하였다. 우선 60mm 배양접시(culture dish)에 2X104/접시 농도로 배양하여 세포부착을 확인한 B16 멜라노마 세포에 CE, WE 및 EE를 각각 10 ㎍/㎖, 100 ㎍/㎖, 1000 ㎍/㎖의 농도로 처리하고, 3일째 되는 날 0.25% 트립신-이디티에이 용액(Trypsin-EDTA solution)을 처리하여 세포를 수확하였다.Cell proliferation was measured by the following method. First, B16 melanoma cells incubated at a concentration of 2 × 10 4 / dish in a 60 mm culture dish to confirm cell adhesion at a concentration of 10 μg / ml, 100 μg / ml and 1000 μg / ml, respectively. Cells were harvested by treatment with 0.25% Trypsin-EDTA solution on the third day.
수확된 세포진탕액 중 500㎕를 떠서 이소톤용액(isotone solution) 10 ㎖과 균일하게 혼합한 후 카울터 계수기(coulter counter ; ZM, Coulter Co., England)로 세포수를 세었는데, 총세포수의 계산은 다음과 같이 하였다.500 μl of the harvested cell shaker was mixed and uniformly mixed with 10 ml of isotone solution and counted with a Coulter counter (ZM, Coulter Co., England). The calculation was as follows.
총세포수 = 카울터 계수기가 센 세포수 X 42 X (세포 진탕액양/ ㎖)Total cell count = number of cells counted by the Coulter counter x 42 X (cell shake amount / ml)
<표 1> 세포증식율TABLE 1 Cell Proliferation Rate
상기 표 1 및 도 1에서 보는 바와 같이, 쑥갓추출물 10 ㎍/㎖ 및 100 ㎍/㎖ 처리구에서는 멜라닌세포 증식억제율이 낮으나, 1000 ㎍/㎖ 처리구에서는 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE) 모두 멜라닌세포 증식억제율이 높음을 알 수 있다.As shown in Table 1 and Figure 1, the wormwood extract 10 ㎍ / ㎖ and 100 ㎍ / ㎖ treated with a low melanocyte proliferation inhibition rate, 1000 ㎍ / ㎖ treated lyophilized extract (CE), mugwort hot water extract (WE) And wormwood ethanol extract (EE) both can be seen that the melanocyte proliferation inhibition rate is high.
<시험예 3> (도파 옥시다제 활성 억제효과 측정)<Test Example 3> (Measurement of Dopa Oxidase Activity Inhibition Effect)
본 발명에 의한 미백조성물에 사용된 쑥갓추출물의 미백효과를 알아보기 위하여 실시예 1 내지 실시예 3에서 제조한 쑥갓 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE) 처리에 의한 멜라닌 생성과정 중 도파에서 도파퀴논으로 전환될 때 관여하는 도파 옥시다제(dopa-oxidase)의 활성억제율을 측정한 결과를 표 2 및 도 2에 나타내었다.Mugwort lyophilized extract (CE), mugwort hot water extract (WE) and mugwort ethanol extract (EE) prepared in Examples 1 to 3 to investigate the whitening effect of mugwort extract used in the whitening composition according to the present invention Table 2 and FIG. 2 show the results of measuring the activity inhibition rate of dopa-oxidase involved in the conversion of dopaquinone to dopaquinone during melanin production.
도파 옥시다제의 활성억제율은 다음과 같은 방법으로 측정하였다. 우선 60mm 배양접시(culture dish)에 2X104/접시 농도로 배양하여 세포부착을 확인한 B16 멜라노마 세포에 CE, WE 및 EE를 각각 10 ㎍/㎖, 100 ㎍/㎖, 1000 ㎍/㎖의 농도로 처리하고, 3일째 되는 날 0.25% 트립신-이디티에이 용액(Trypsin-EDTA solution)을 처리하여 세포를 수확하여 카울터 계수기로 세포수를 세었다.The activity inhibition rate of dopa oxidase was measured by the following method. First, B16 melanoma cells incubated at a concentration of 2 × 10 4 / dish in a 60 mm culture dish to confirm cell adhesion at a concentration of 10 μg / ml, 100 μg / ml and 1000 μg / ml, respectively. Cells were harvested by treatment with 0.25% Trypsin-EDTA solution on the third day and counted with a Coulter counter.
그런 다음 처리군당 2X105세포를 1.7ml 튜브에 각각 나누어 담고 여기에 1mM L-도파(Sigma Chemical Co., St, Louis, Missouri)가 함유된 세포분쇄용액 100㎕를 첨가하고 1시간 동안 37℃에서 반응시킨 후 분광광도계로 490nm에서 흡광도를측정하였다.Then, divide 2X10 5 cells per treatment group into 1.7 ml tubes, add 100 μl of 1 mM L-dopa (Sigma Chemical Co., St, Louis, Missouri), and then dissolve the cell grinding solution at 37 ° C. for 1 hour. After the reaction, the absorbance was measured at 490 nm with a spectrophotometer.
<표 2> 도파 옥시다제 활성TABLE 2 Dopa Oxidase Activity
상기 표 2 및 도 2에서 보는 바와 같이, 쑥갓추출물 10 ㎍/㎖ 및 100 ㎍/㎖ 처리구에서는 도파 옥시다제의 활성억제율이 낮으나, 1000 ㎍/㎖ 처리구에서는 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE) 모두 도파 옥시다제 활성억제율이 높음을 알 수 있다.As shown in Table 2 and FIG. 2, the activity inhibition rate of dopa oxidase was low in the 10 ㎍ / ml and 100 ㎍ / ml treatment of mugwort extract, but the freeze-dried extract (CE) and mugwort hot water extract ( Both WE) and wormwood ethanol extract (EE) showed high dopa oxidase activity inhibition rate.
<시험예 4> (멜라닌 생성량 측정)<Test Example 4> (Melanin production amount measurement)
본 발명에 의한 미백조성물에 사용된 쑥갓추출물의 미백효과를 알아보기 위하여 실시예 1 내지 실시예 3에서 제조한 쑥갓 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE) 처리에 의한 멜라닌생성량을 측정한 결과를 표 3 및 도 3에 나타내었다.Mugwort lyophilized extract (CE), mugwort hot water extract (WE) and mugwort ethanol extract (EE) prepared in Examples 1 to 3 to investigate the whitening effect of mugwort extract used in the whitening composition according to the present invention The results of measuring the amount of melanin production by are shown in Table 3 and FIG.
멜라닌 생성량은 다음과 같은 방법으로 측정하였다. 우선 60mm 배양접시(culture dish)에 2X104/접시 농도로 배양하여 세포부착을 확인한 B16 멜라노마 세포에 CE, WE 및 EE를 각각 10 ㎍/㎖, 100 ㎍/㎖, 1000 ㎍/㎖의 농도로 처리하고, 3일째 되는 날 0.25% 트립신-이디티에이 용액(Trypsin-EDTA solution)을처리하여 세포를 수확하여 카울터 계수기로 세포수를 세었다.Melanin production was measured by the following method. First, B16 melanoma cells incubated at a concentration of 2 × 10 4 / dish in a 60 mm culture dish to confirm cell adhesion at a concentration of 10 μg / ml, 100 μg / ml and 1000 μg / ml, respectively. Cells were harvested by treatment with 0.25% Trypsin-EDTA solution on the third day and counted with a Coulter counter.
그런 다음 각 처리군별로 2X105세포수 당 100㎕의 1N NaOH 용액을 넣고 37℃에서 12시간 동안 세포를 용해시킨 후, 완전히 용해된 샘플의 흡광도를 측정하기 전에 합성멜라닌(Sigma. Chemical Co., St, Louis, Misso) 10mg을 1N NaOH 10㎖에 용해시켜 스탁용액(stock solution) 1mg/㎖을 제조한 뒤 700g/㎖, 300g/㎖, 100g/㎖, 70g/㎖, 30g/㎖, 10g/㎖, 7g/㎖, 3g/㎖, 1g/㎖, 0.1g/㎖ 및 0g/㎖ 농도로 희석하여 표준용액(standard solution)을 제조하였다.Then, 100 μl of 1N NaOH solution per 2 × 10 5 cell number was added to each treatment group, and the cells were lysed at 37 ° C. for 12 hours, and then synthetic melanin (Sigma. Chemical Co., St, Louis, Misso) 10mg dissolved in 10ml of 1N NaOH to prepare 1mg / ml of stock solution, 700g / ml, 300g / ml, 100g / ml, 70g / ml, 30g / ml, 10g / A standard solution was prepared by diluting to ml, 7g / ml, 3g / ml, 1g / ml, 0.1g / ml and 0g / ml.
샘플과 표준용액을 96 웰검정판(well assy plate)에 넣고 490nm에서 분광광도계로 흡광도를 측정한 다음, 측정된 흡광도값을 합성 멜라닌으로 작성된 표준직선에 적용하여 멜라닌량으로 환산하였다.The sample and the standard solution were placed in a 96 well assy plate, and the absorbance was measured with a spectrophotometer at 490 nm, and then the measured absorbance value was applied to a standard straight line made of synthetic melanin, and converted into melanin amount.
<표 3> 멜라닌 생성량Table 3 Melanin Production
상기 표 3 및 도 3에서 보는 바와 같이, 쑥갓추출물 10 ㎍/㎖ 및 100 ㎍/㎖ 처리구에서는 멜라닌 생성억제율이 낮으나, 1000 ㎍/㎖ 처리구에서는 동결건조 추출물(CE), 쑥갓 열수추출물(WE) 및 쑥갓 에탄올 추출물(EE) 모두 멜라닌 생성억제율이 높음을 알 수 있다.As shown in Table 3 and FIG. 3, the melanin production inhibition rate was low in the 10 ㎍ / ㎖ and 100 ㎍ / ㎖ treatment mugwort extract, but lyophilized extract (CE), mugwort hot water extract (WE) and 1000 ㎍ / ㎖ treatment It can be seen that wormwood ethanol extract (EE) has a high melanin production inhibition rate.
<시험예 5> (안정성 시험)<Test Example 5> (stability test)
본 발명에 의한 쑥갓추출물을 함유하는 미백조성물의 안정성을 시험하기 위하여 실시예 4에서 제조한 영양화장수 및 실시예 5에서 제조한 크림을 4℃, 상온(25℃), 40℃ 및 50℃에서 3개월 동안 방치시킨 후, 각 조성물의 안정성을 관찰한 결과를 표 4에 나타내었다.In order to test the stability of the whitening composition containing wormwood extract according to the present invention, the nutrient lotion prepared in Example 4 and the cream prepared in Example 5 were used at 4 ° C, room temperature (25 ° C), 40 ° C and 50 ° C. After being left for months, the results of observing the stability of each composition are shown in Table 4.
<표 4>. 안정성 시험결과TABLE 4 Stability Test Results
상기 표 4에서 보는 바와 같이, 본 발명에 의한 미백조성물은 장시간 경과 후에도 안정성을 유지함을 알 수 있다.As shown in Table 4, it can be seen that the whitening composition according to the present invention maintains stability even after a long time.
본 발명에 의한 미백조성물은 천연소재인 쑥갓추출물을 함유하고 있어 멜라닌세포의 증식억제 및 멜라닌의 생성에 관여하는 타이로시나제의 활성을 억제하여 멜라닌의 생성량을 감소시킴으로써 미백효과를 갖음과 동시에 장시간 보관시에도 안정성을 유지할 수 있다.The whitening composition according to the present invention contains wormwood extract, which is a natural material, has a whitening effect by reducing the amount of melanin by inhibiting the activity of tyrosinase involved in the proliferation of melanocytes and the production of melanin. Stability can be maintained even during storage.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020025045A KR20030086849A (en) | 2002-05-07 | 2002-05-07 | A composition for whitening containing crown daisy extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020025045A KR20030086849A (en) | 2002-05-07 | 2002-05-07 | A composition for whitening containing crown daisy extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20030086849A true KR20030086849A (en) | 2003-11-12 |
Family
ID=32381844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020025045A KR20030086849A (en) | 2002-05-07 | 2002-05-07 | A composition for whitening containing crown daisy extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20030086849A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100896520B1 (en) * | 2007-12-03 | 2009-05-08 | 행복의샘 (주) | Mulberry juice containing baekbaekpi and its manufacturing method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58135803A (en) * | 1982-02-05 | 1983-08-12 | Noriko Sugano | Preparation of nutrient beauty lotion |
WO1999013856A1 (en) * | 1997-09-18 | 1999-03-25 | L'oreal | Use of at least an extract of the genus chrysanthemum for stimulating skin and/or hair pigmentation |
KR101094278B1 (en) * | 2010-03-09 | 2011-12-19 | 삼성모바일디스플레이주식회사 | Organic light emitting display |
KR101102340B1 (en) * | 2010-03-23 | 2012-01-03 | 한국과학기술원 | 3D inductor |
-
2002
- 2002-05-07 KR KR1020020025045A patent/KR20030086849A/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58135803A (en) * | 1982-02-05 | 1983-08-12 | Noriko Sugano | Preparation of nutrient beauty lotion |
WO1999013856A1 (en) * | 1997-09-18 | 1999-03-25 | L'oreal | Use of at least an extract of the genus chrysanthemum for stimulating skin and/or hair pigmentation |
KR101094278B1 (en) * | 2010-03-09 | 2011-12-19 | 삼성모바일디스플레이주식회사 | Organic light emitting display |
KR101102340B1 (en) * | 2010-03-23 | 2012-01-03 | 한국과학기술원 | 3D inductor |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100896520B1 (en) * | 2007-12-03 | 2009-05-08 | 행복의샘 (주) | Mulberry juice containing baekbaekpi and its manufacturing method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101971837B1 (en) | Cosmetic composition for improving skin whitening and wrinkle comprising adventitious root extract of Centella asiatica as effective component | |
KR20170132388A (en) | Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata | |
KR102594733B1 (en) | Cosmetic composition for improving melasma, freckles, whitenings and wrinkle comprising extract of fermented chestnut inner shell, angelica dahurica, portulace oleracea, armeniacae and mori dadicis cortex and preparation method thereof | |
KR20200138870A (en) | Composition for preventing or improving skin aging comprising an extract of rhodiola sachalinesis fermented by bovista plumbea | |
CN113631227B (en) | Anti-aging agents, antioxidants, anti-inflammatory agents, whitening agents, and cosmetics | |
KR101071414B1 (en) | Whitening composition containing guanavana extract as an active ingredient | |
KR102489463B1 (en) | Composition for whitening comprising extract of microwave treated Dendropanax morbifera | |
KR101295336B1 (en) | A Cosmetic Composition Comprising Fagopyrum Tataricum Extract And Preparing Method Thereof | |
KR102471009B1 (en) | Cosmetic composition containing Albiggia kalkora extract for skin whitening and improving wrinkles | |
KR20030085771A (en) | A composition for whitening containing dropwort extract | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR102006665B1 (en) | Anti-oxidant, anti-inflammatory, whitening and moisturizing cosmetic composition comprising the mixed herbal extract of silver weed, heather, and milk thistle as an active ingredient and preparation method of the same | |
KR20030086849A (en) | A composition for whitening containing crown daisy extract | |
KR20230079615A (en) | Liposome comprsings barley sprout extract and vitamin tree fruit extract and cosmetic compositions containing the same | |
KR20030090126A (en) | A composition for whitening containing fruit of Chinese quince extract | |
KR20040076103A (en) | Method of producing a cosmetic composition which contains mixed plant extracts | |
KR20190063600A (en) | Composition for skin whitening comprising extract of stichopus japonicas red | |
KR102356144B1 (en) | Cosmetic composition and health functional food for skin whitening and anti-wrinkle | |
KR102702220B1 (en) | Codonopsis lanceolata and Making method of the same | |
KR102374884B1 (en) | Cosmetic composition containing the extract of dendropanax morbifera and wild ginseng as active ingredient | |
KR101068808B1 (en) | Composition for Whitening Containing Extract of Delonix regia | |
KR101079713B1 (en) | Composition for Whitening Containing Extract of Talinum crassifolium as an active ingredient | |
KR20010025288A (en) | Protocatechuic aldehyde as a tyrosinase inhibitor and herb extract containing the compound | |
KR20030005721A (en) | A cosmetic composition containing an extract of trichosanthes kirilowii | |
KR101791425B1 (en) | Cosmetic composition for skin-whitening comprising mixture extract of Coptis chinensis, EVODIA RUTAECARPA and Paeonia lactiflora P. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20020507 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20040730 Patent event code: PE09021S01D |
|
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20041025 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20040730 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |